| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PALI | Common Stock, par value $0.01 | Award | $3,312 | +666 | +9.8% | $4.97 | 7,437 | 20 May 2024 | Direct | F1 |
| holding | PALI | Common Stock, par value $0.01 | 51 | 20 May 2024 | By FCW Investments, LLC | F2 |
| Id | Content |
|---|---|
| F1 | Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended ("ESPP") for the ESPP purchase period from November 21, 2023 through May 20, 2024. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on May 20, 2024. |
| F2 | Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity. |